MANNATECH INC Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
MANNATECH INC (MTEX) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of -$79.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2022-03-15
- MANNATECH INC unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2021 was -$79.00K.
- MANNATECH INC unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2020 was $0.00.
- MANNATECH INC unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- MANNATECH INC unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2015 was $17.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2021-12-31 | -$79.00K 10-K · filed 2022-03-15 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2016-12-31 | $0.00 10-K · filed 2017-03-14 |
| 2015-12-31 | $17.00K 10-K · filed 2017-03-14 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |